BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28

• Business

  3SBio Inc. Announces Unaudited First Quarter 2010 Results

  May 17, 2010

   · 

  13 min read
• Drug Development

  FibroGen, Inc. Reports Preclinical Data Showing that FG-3019 Reversed the Process of Fibrosis in the Lung

  May 17, 2010

   · 

  1 min read
• Biotech Bay

  Pearl Therapeutics Receives TiE50 Entrepreneur Award

  May 17, 2010

   · 

  2 min read
• Business

  Soligenix Reports First Quarter 2010 Financial Results and Reviews Accomplishments

  May 17, 2010

   · 

  6 min read
• FDA

  Response Biomedical Granted Class 3 Medical Device License by Health Canada to Market RSV Assay in Canada

  May 17, 2010

   · 

  6 min read
• Genetown

  Stemgent Finds $5.6 Million More

  May 17, 2010

   · 

  1 min read
• Pharm Country

  Oishei Makes First Bio-medical Investment in AndroBioSys

  May 17, 2010

   · 

  1 min read
• Business

  Scientific Industries Inc. Reports Results for Periods Ended March 31, 2010

  May 17, 2010

   · 

  1 min read
• Business

  Pressure BioSciences, Inc. to Discuss First Quarter 2010 Financial Results and Provide Business Update

  May 17, 2010

   · 

  1 min read
• Drug Development

  Hemispherx Biopharma Prepares Application to Initiate Phase II Clinical Trials in China With Ampligen(R)

  May 17, 2010

   · 

  1 min read